Nutriband (NASDAQ:NTRB) Now Covered by Analysts at Noble Financial

Noble Financial began coverage on shares of Nutriband (NASDAQ:NTRB) in a research note released on Wednesday, Marketbeat.com reports. The brokerage issued an outperform rating and a $13.00 price target on the stock.

Nutriband Stock Performance

Shares of Nutriband stock opened at $7.34 on Wednesday. Nutriband has a one year low of $2.22 and a one year high of $9.60. The business has a 50-day simple moving average of $4.44 and a 200-day simple moving average of $5.40. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.83 and a current ratio of 4.96. The company has a market cap of $81.52 million, a PE ratio of -10.34 and a beta of 0.99.

Nutriband (NASDAQ:NTRB) last released its quarterly earnings data on Tuesday, December 3rd. The company reported ($0.12) EPS for the quarter. Nutriband had a negative net margin of 338.51% and a negative return on equity of 54.49%.

Nutriband Company Profile

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.